EXIDUR Trademark

Trademark Overview

On Monday, November 29, 2010, a trademark application was filed for EXIDUR with the United States Patent and Trademark Office. The USPTO has given the EXIDUR trademark a serial number of 85185857. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 1, 2014. This trademark is owned by JOHNSON & JOHNSON. The EXIDUR trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceuticals for the treatment of ophthalmic diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases
exidur

General Information

Serial Number85185857
Word MarkEXIDUR
Filing DateMonday, November 29, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 1, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2011

Trademark Statements

Goods and ServicesHuman pharmaceuticals for the treatment of ophthalmic diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 2, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001

Trademark Events

Event DateEvent Description
Monday, December 1, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 1, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 15, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 12, 2014EXTENSION 5 GRANTED
Thursday, April 10, 2014EXTENSION 5 FILED
Thursday, April 10, 2014TEAS EXTENSION RECEIVED
Saturday, October 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2013EXTENSION 4 GRANTED
Thursday, October 3, 2013EXTENSION 4 FILED
Thursday, October 3, 2013TEAS EXTENSION RECEIVED
Friday, March 22, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 21, 2013EXTENSION 3 GRANTED
Wednesday, March 20, 2013EXTENSION 3 FILED
Wednesday, March 20, 2013TEAS EXTENSION RECEIVED
Tuesday, September 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 24, 2012EXTENSION 2 GRANTED
Friday, September 21, 2012EXTENSION 2 FILED
Monday, September 24, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 21, 2012TEAS EXTENSION RECEIVED
Tuesday, April 3, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 29, 2012EXTENSION 1 GRANTED
Thursday, March 29, 2012EXTENSION 1 FILED
Thursday, March 29, 2012TEAS EXTENSION RECEIVED
Thursday, March 29, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 25, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 30, 2011PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2011NOTICE OF PUBLICATION
Sunday, July 24, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, July 24, 2011ASSIGNED TO LIE
Tuesday, June 28, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 27, 2010LETTER OF SUSPENSION MAILED
Thursday, December 23, 2010SUSPENSION LETTER WRITTEN
Thursday, December 16, 2010ASSIGNED TO EXAMINER
Thursday, December 2, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 2, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

exidur diseases muscle smooth disorders gastro intestinal wrinkles dystonias ophthalmic pharmaceuticals